Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Commercialization revenue	$ 28,640	$ 793	$ 55,997	$ 1,677
License and collaboration revenue	0	164	0	506
Total revenue	28,640	957	55,997	2,183
Costs and operating expenses:
Cost of commercialization revenue	4,627	2,895	6,612	3,111
Research and development expenses	33,332	56,141	78,838	118,297
General and administrative expenses	8,912	13,335	20,025	27,207
Total costs and operating expenses	46,871	72,371	105,475	148,615
Loss from operations	(18,231)	(71,414)	(49,478)	(146,432)
Other income (expense), net:
Interest income	450	1,695	1,054	3,497
Interest expense	(1,262)	(1,378)	(2,415)	(2,714)
Other income (expense), net	(6)	(10)	62	(207)
Total other income (expense), net	(818)	307	(1,299)	576
Loss before provision for (benefit from) income taxes	(19,049)	(71,107)	(50,777)	(145,856)
Provision for (benefit from) income taxes	0	1	24	23
Net income (loss)	(19,049)	(71,108)	(50,801)	(145,879)
Other comprehensive gain (loss):
Unrealized gain (loss) on available-for-sale securities	41	304	190	1,134
Comprehensive income (loss)	$ (19,008)	$ (70,804)	$ (50,611)	$ (144,745)
Basic net loss per common share	$ (3.1)	$ (16.91)	$ (8.64)	$ (34.89)
Diluted net loss per common share	$ (3.1)	$ (16.91)	$ (8.64)	$ (34.89)
Basic weighted-average shares outstanding	6,143	4,204	5,883	4,181
Diluted weighted-average shares outstanding	6,143	4,204	5,883	4,181